1. Home
  2. CRBP vs SCWX Comparison

CRBP vs SCWX Comparison

Compare CRBP & SCWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBP
  • SCWX
  • Stock Information
  • Founded
  • CRBP 2009
  • SCWX 1999
  • Country
  • CRBP United States
  • SCWX United States
  • Employees
  • CRBP N/A
  • SCWX N/A
  • Industry
  • CRBP Biotechnology: Pharmaceutical Preparations
  • SCWX Computer Software: Prepackaged Software
  • Sector
  • CRBP Health Care
  • SCWX Technology
  • Exchange
  • CRBP Nasdaq
  • SCWX Nasdaq
  • Market Cap
  • CRBP 594.7M
  • SCWX 655.9M
  • IPO Year
  • CRBP N/A
  • SCWX 2016
  • Fundamental
  • Price
  • CRBP $50.04
  • SCWX $8.28
  • Analyst Decision
  • CRBP Strong Buy
  • SCWX Sell
  • Analyst Count
  • CRBP 5
  • SCWX 4
  • Target Price
  • CRBP $76.20
  • SCWX $7.08
  • AVG Volume (30 Days)
  • CRBP 261.5K
  • SCWX 93.7K
  • Earning Date
  • CRBP 08-06-2024
  • SCWX 09-05-2024
  • Dividend Yield
  • CRBP N/A
  • SCWX N/A
  • EPS Growth
  • CRBP N/A
  • SCWX N/A
  • EPS
  • CRBP N/A
  • SCWX N/A
  • Revenue
  • CRBP N/A
  • SCWX $346,352,000.00
  • Revenue This Year
  • CRBP N/A
  • SCWX N/A
  • Revenue Next Year
  • CRBP N/A
  • SCWX $4.15
  • P/E Ratio
  • CRBP N/A
  • SCWX N/A
  • Revenue Growth
  • CRBP N/A
  • SCWX N/A
  • 52 Week Low
  • CRBP $3.03
  • SCWX $5.40
  • 52 Week High
  • CRBP $61.90
  • SCWX $9.76
  • Technical
  • Relative Strength Index (RSI)
  • CRBP 40.84
  • SCWX 58.24
  • Support Level
  • CRBP $54.23
  • SCWX $7.34
  • Resistance Level
  • CRBP $61.72
  • SCWX $9.76
  • Average True Range (ATR)
  • CRBP 4.16
  • SCWX 0.62
  • MACD
  • CRBP -0.95
  • SCWX 0.04
  • Stochastic Oscillator
  • CRBP 11.83
  • SCWX 43.73

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About SCWX SecureWorks Corp.

SecureWorks Corp is a cybersecurity provider of technology-driven solutions singularly focused on protecting its customers by outpacing and outmaneuvering the adversary. The company offers its customers the following services; software-as-a-service, or SaaS, solutions, managed solutions, and professional services, including incident response and adversarial services. Its solutions enable organizations to fortify their cyber defenses to prevent security breaches, detect malicious activity in real-time, prioritize and respond to security incidents, and predict emerging threats. The company's products consist of MDR, XDR, Threat Hunting, Log Management, NGAV, EDR, IDPS.

Share on Social Networks: